Tuesday, June 13, 2006

Evolution of a Biopharmaceutical Company: Nektar Therapeutics

Date: 04/11/06
Length: 00:11:48
Size: 5.5MB

Thought Leader: Hoyoung Huh, M.D. Ph.D., Senior VP, Business Development — Nektar Therapeutics

Nektar has crossed the chasm from a drug-delivery-technology company to a product-development company. Dr. Huh describes how they made the transition, and what to look for from them in the future.

Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

No comments: